Suzana Radulovic, MD, Mikila R. Jacobson, PhD, Stephen R

Slides:



Advertisements
Similar presentations
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Advertisements

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy  Erik Wambre, PhD, Jonathan.
Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope- dependent manner  Erik Wambre, PhD, Jonathan H. DeLong, BSc, Eddie.
Allergen immunotherapy: A practice parameter third update
Expression of IL-9 receptor α chain on human germinal center B cells modulates IgE secretion  Lama M. Fawaz, PhD, Ehssan Sharif-Askari, PhD, Oumnia Hajoui,
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Obstructive sleep apnea syndrome and inflammation
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma  Paweł Majak, MD, PhD, Błażej Rychlik, PhD, Łukasz Pułaski,
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of.
A history of pollen mapping and surveillance: The relations between natural history and clinical allergy  Gregg Mitman, PhD  Journal of Allergy and Clinical.
T-cell regulation in chronic paranasal sinus disease
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Physician needs in health informatics: Just ask the docs
Peter M. Wolfgram, MD, David B. Allen, MD 
Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut  Alexandra F. Santos, MD, MSc,
Alvin W. L. Schadenberg, MD, Theo van den Broek, MD, Marten A
Benjamin T. Prince, MD, Msci, Ashley L. Devonshire, MD, MPH, Kristin A
Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope- dependent manner  Erik Wambre, PhD, Jonathan H. DeLong, BSc, Eddie.
Mast cell activation syndrome: Proposed diagnostic criteria
Prathap Pillai, MD, Cailong Fang, PhD, Yih-Chih Chan, PhD, Mohamed H
A novel allergen-specific therapy with CD40-silenced B cells and dendritic cells  Motohiko Suzuki, MD, PhD, Makoto Yokota, MD, PhD, Yoshihisa Nakamura,
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis  Chris Corrigan,
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Phillip Lieberman, MD, David Golden, MD 
The role of the mast cell in the pathophysiology of asthma
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Expression of IL-9 receptor α chain on human germinal center B cells modulates IgE secretion  Lama M. Fawaz, PhD, Ehssan Sharif-Askari, PhD, Oumnia Hajoui,
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy  Erik Wambre, PhD, Jonathan.
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
What is an “eosinophilic phenotype” of asthma?
Meri K. Tulic, BSc, PhD, David Andrews, MD, Maxine L
Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus–specific immunotherapy  Yi-Giien Tsai, MD,
Direct ex vivo analysis of allergen-specific CD4+ T cells
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Geographic variability in childhood asthma prevalence in Chicago
Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge  John-Paul Oliveria,
Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells  Sun Ying, MD, PhD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection  Saurabh Mehandru, MD, Klara Tenner-Racz, MD, Paul Racz, MD, PhD, Martin.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells  Troy R. Torgerson, MD,
Biology of nasal polyposis
Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States  Jonathan I. Silverberg, MD, PhD, MPH, Marc.
Wasp venom immunotherapy expands a subpopulation of CD4+CD25+ forkhead box protein 3–positive regulatory T cells expressing the T-cell receptor Vβ2 and.
Thunderstorm-related asthma attacks
Reply Journal of Allergy and Clinical Immunology
Human basophils may not undergo modulation by DC-SIGN and mannose receptor– targeting immunotherapies due to absence of receptors  Mrinmoy Das, MSc, Caroline.
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy  Kayhan T. Nouri-Aria, PhD, FRCPath, Charles.
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
Dendritic cells in nasal mucosa of subjects with different allergic sensitizations  Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,
Environmental factors and eosinophilic esophagitis
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis  Christine Riedhammer,
Presentation transcript:

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa  Suzana Radulovic, MD, Mikila R. Jacobson, PhD, Stephen R. Durham, MD, Kayhan T. Nouri-Aria, PhD  Journal of Allergy and Clinical Immunology  Volume 121, Issue 6, Pages 1467-1472.e1 (June 2008) DOI: 10.1016/j.jaci.2008.03.013 Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Immunofluorescence staining of tonsillar sections and nasal sections from GP-IT–treated patients. A, Foxp3+CD4+ cells in the tonsil (inset shows control after preadsorption with human Foxp3 peptide, magnification ×200). B, Foxp3+CD4+ cells in the nose (magnification ×400). C, CD3+CD25+Foxp3+ cells in the tonsil (magnification ×200). D, Foxp3+CD3+CD25+ cells in the nose (magnification ×400). E and F, Foxp3+CD3+IL-10+ cells in the nose (magnification ×1000). G, Percentage of Foxp3+ cells that were CD3+, IL-10+, or CD3+IL-10+. Journal of Allergy and Clinical Immunology 2008 121, 1467-1472.e1DOI: (10.1016/j.jaci.2008.03.013) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Foxp3+(A), Foxp3+CD25+(B), and Foxp3+CD4+(C) cells in patients with hay fever, GP-IT–treated patients, and nonatopic control subjects. Statistical analysis was performed by using the Mann-Whitney U test. Journal of Allergy and Clinical Immunology 2008 121, 1467-1472.e1DOI: (10.1016/j.jaci.2008.03.013) Copyright © 2008 American Academy of Allergy, Asthma & Immunology Terms and Conditions